Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LICC: L-BLP25 in Patients With Colorectal Carcinoma After Curative Resection of Hepatic Metastases - a Randomized, Placebo-controlled, Multicenter, Multinational, Double Blinded Phase II Trial

NCT01462513 is registered in ClinicalTrials.gov with Prof. Dr. Carl Schimanski as lead sponsor.

NCT NCT01462513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01462513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LICC: L-BLP25 in Patients With Colorectal Carcinoma After Curative Resection of Hepatic Metastases - a Randomized, Placebo-controlled, Multicenter, Multinational, Double Blinded Phase II Trial
Lead sponsor
Prof. Dr. Carl Schimanski
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2011
Completion date
January 31, 2018
Enrollment
122 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

colon carcinoma, rectum carcinoma